Wound Care

Nearly half of the surveyed patients identified a negative impact of their wounds on daily life, particularly at work.

Although both methods were well tolerated, enzymatic debridement worked faster in randomized controlled trials.

Satisfaction levels rose and recovery outcomes greatly improved with Cicaglocal compared to the placebo.

Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.

A recent study found standard burn assessment tools often fail to accurately evaluate injuries in darker skin tones, leading to misdiagnosis and delays.

A 25-day BioLab study revealed their protein-rich wound gel outpaces alternatives, setting the stage for clinical trials.

The company is currently recruiting participants to demonstrate the benefits of its BioREtain technology.

Designed to mimic natural tissue scaffolds, DermiSphere hDRT offers innovative support for cellular infiltration and healing in reconstructive surgery.

A recent analysis found primary closure in HS surgery has higher recurrence rates, while secondary intention healing avoids complications but prolongs recovery.

Compared to a stapling device, Xkin reduced scarring, pain, and infection risk more effectively in surgical and trauma wounds.

Cutiss plans to have full phase 2 data in early 2025.

In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.

The Technology Breakthrough designation will enable health care providers to access exclusive pricing and terms for the solution in pediatric burn care.

The FDA no longer restricts the donation of human cells, tissues, cellular or tissue-based products, human milk, ova, sperm, or organs for transplantation for patients who receive StrataGraft.

Click here to answer this week's poll.

Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.

Researchers tested bovine sialogylcoproteins on human dermal fibroblasts.

CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.

Such factors may include transepidermal water loss and skin barrier function.

Researchers also investigated how electric stimulation could be used to speed up wound healing in connection with diabetes, which affects wound healing due to impaired circulation and nerve damage.

Cutiss AG hopes to provide a safe and effective skin substitute for patients needing a skin graft after a severe burn.

Convatec’s InnovaBurn device manages surgical wounds and burns, including second-degree burns.

Robert S. Kirsner, MD, PhD, presents new pearls in wound healing science that could change how medical professionals approach patient care.

New products focus on multimodal healing with absorption, antibacterial, and regenerative properties.